Sign in
Stories
Genmab's Share Capital Increase
Share
Biopharma Companies Announce Public Offe...
Companies Report Financial Results
NBPE's Market Updates
Acerus Joins First Generation Capital
Annual General Meeting Announcement
BMY Expands Portfolio with RayzeBio Acqu...
Overview
API
Genmab A/S is set to increase its share capital by 18,700 shares following the exercise of employee warrants. The move will generate DKK 27.2 million in proceeds and will be listed on Nasdaq Copenhagen.
Ask a question
How might the increase in share capital impact Genmab's financial position?
How might this capital increase influence Genmab's long-term growth and strategy?
What could be the implications of the employee warrant exercise on Genmab's stock market performance?
Article Frequency
0.2
0.4
0.6
0.8
1.0
May 2023
Jun 2023
Jul 2023
Coverage